Can we use mice to study schizophrenia?

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 373, Issue 1742, 2018, Pages

  Canetta, Sarah ^a,b   Kellendonk, Christoph ^a,b  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Behaviour; Cognition; Mice; Neuronal circuitry; Schizophrenia

Indexed keywords

COGNITION; DISABILITY; HYPOTHESIS TESTING; NUMERICAL MODEL; PHYSIOLOGY; RISK FACTOR; RODENT;

MUS; RODENTIA;

ANIMAL; DISEASE MODEL; GENETICS; HUMAN; MOUSE; PATHOPHYSIOLOGY; SCHIZOPHRENIA;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; SCHIZOPHRENIA;

EID: 85040926153     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2017.0032     Document Type: Article

References (58)

1. Conn PJ, Roth BL. 2008 Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settings. Neuropsychopharmacology 33, 2048–2060. (doi:10.1038/sj.npp.1301638)
2. Nithianantharajah J, McKechanie AG, Stewart TJ, Johnstone M, Blackwood DH, St Clair D, Grant SG, Bussey TJ, Saksida LM. 2015 Bridging the translational divide: identical cognitive touchscreen testing in mice and humans carrying mutations in a disease-relevant homologous gene. Sci. Rep. 5, 14613. (doi:10.1038/srep14613)
3. Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA. 2010 Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463, 49–53. (doi:10.1038/nature08637)
4. Tandon R, Nasrallah HA, Keshavan MS. 2009 Schizophrenia, ‘just the facts’ 4. Clinical features and conceptualization. Schizophr. Res. 110, 1–23. (doi:10.1016/j.schres.2009.03.005)
5. Green MF, Kern RS, Braff DL, Mintz J. 2000 Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘right stuff’? Schizophr. Bull. 26, 119–136.
6. Keefe RS et al. 2007 Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch. Gen. Psychiatry 64, 633–647.
7. Schizophrenia Working Group of the Psychiatric Genomics C. 2014 Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427. (doi:10.1038/nature13595)
8. Sekar A et al. 2016 Schizophrenia risk from complex variation of complement component 4. Nature 530, 177–183. (doi:10.1038/nature16549)
9. Karayiorgou M, Simon TJ, Gogos JA. 2010 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 11, 402–416. (doi:10.1038/nrn2841)
10. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C. 2001 Neuropsychiatric disorders in the 22q11 deletion syndrome. Genet. Med. 3, 79–84.
11. Murphy KC, Jones LA, Owen MJ. 1999 High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 56, 940–945.
12. Paylor R, Lindsay E. 2006 Mouse models of 22q11 deletion syndrome. Biol. Psychiatry 59, 1172–1179. (doi:10.1016/j.biopsych.2006.01.018)
13. Drew LJ et al. 2011 The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int. J. Dev. Neurosci. 29, 259–281. (doi:10.1016/j.ijdevneu. 2010.09.007)
14. van Amelsvoort T, Henry J, Morris R, Owen M, Linszen D, Murphy K, Murphy D. 2004 Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr. Res. 70, 223–232. (doi:10.1016/j.schres.2003.10.004)
15. Stark KL et al. 2008 Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760. (doi:10.1038/ng.138)
16. Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. 2010 Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 464, 763–767. (doi:10.1038/nature08855)
17. Bahner F, Meyer-Lindenberg A. 2017 Hippocampal-prefrontal connectivity as a translational phenotype for schizophrenia. Eur. Neuropsychopharmacol. 27, 93–106. (doi:10.1016/j.euroneuro.2016.12.007)
18. Dierks T, Linden DE, Jandl M, Formisano E, Goebel R, Lanfermann H, Singer W. 1999 Activation of Heschl’s gyrus during auditory hallucinations. Neuron 22, 615–621.
19. Chun S, Westmoreland JJ, Bayazitov IT, Eddins D, Pani AK, Smeyne RJ, Yu J, Blundon JA, Zakharenko SS. 2014 Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models. Science 344, 1178–1182. (doi:10.1126/science.1253895)
20. Brown AS, Derkits EJ. 2010 Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 167, 261–280. (doi:10.1176/appi.ajp.2009.09030361)
21. Canetta S, Sourander A, Surcel HM, Hinkka-Yli-Salomaki S, Leiviska J, Kellendonk C, McKeague IW, Brown AS. 2014 Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am. J. Psychiatry 171, 960–968. (doi:10.1176/appi.ajp.2014.13121579)
22. Canetta SE et al. 2014 Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring. Am. J. Psychiatry 171, 557–563. (doi:10.1176/appi.ajp.2013.13070943)
23. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES. 2004 Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61, 774–780. (doi:10.1001/archpsyc.61.8.774)
24. Meyer U, Feldon J. 2012 To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 62, 1308– 1321. (doi:10.1016/j.neuropharm.2011.01.009)
25. Shi L, Fatemi SH, Sidwell RW, Patterson PH. 2003 Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23, 297–302.
26. Shi L, Patterson PH. 2005 Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int. J. Dev. Neurosci. 23, 299–305. (doi:10.1016/j. ijdevneu.2004.05.005)
27. Irving WL et al. 2000 Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 107, 1282–1289.
28. Lewis DA, Hashimoto T, Volk DW. 2005 Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312–324. (doi:10.1038/nrn1648)
29. Hoftman GD, Datta D, Lewis DA. 2017 Layer 3 excitatory and inhibitory circuitry in the prefrontal cortex: developmental trajectories and alterations in schizophrenia. Biol. Psychiatry 81, 862–873. (doi:10.1016/j.biopsych.2016.05.022)
30. Frankle WG, Cho RY, Prasad KM, Mason NS, Paris J, Himes ML, Walker C, Lewis DA, Narendran R. 2015 In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients. Am. J. Psychiatry 172, 1148–1159. (doi:10.1176/appi.ajp.2015.14081031)
31. Uhlhaas PJ, Singer W. 2015 Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities. Biol. Psychiatry 77, 1001–1009. (doi:10.1016/j. biopsych.2014.11.019)
32. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. 2008 Adult brain and behavioral pathological markers of prenatal immune challenge during early/ middle and late fetal development in mice. Brain Behav. Immun. 22, 469–486. (doi:10.1016/j.bbi. 2007.09.012)
33. Canetta S, Bolkan S, Padilla-Coreano N, Song LJ, Sahn R, Harrison NL, Gordon JA, Brown A, Kellendonk C. 2016 Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons. Mol. Psychiatry. 21, 956–968. (doi:10.1038/mp.2015.222)
34. Brown AS et al. 2009 Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am. J. Psychiatry 166, 683–690. (doi:10.1176/appi.ajp.2008.08010089)
35. Weinberger DR, Berman KF. 1996 Prefrontal function in schizophrenia: confounds and controversies. Phil. Trans. R. Soc. Lond. B 351, 1495–1503.
36. Barch DM, Ceaser A. 2012 Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn. Sci. 16, 27–34. (doi:10.1016/j.tics.2011.11.015)
37. Kolb B, Whishaw IQ. 1983 Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients. J. Nerv. Ment. Dis. 171, 435–443.
38. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. 2009 Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch. Gen. Psychiatry 66, 811–822. (doi:10.1001/archgenpsychiatry.2009.91)
39. Woodward ND, Karbasforoushan H, Heckers S. 2012 Thalamocortical dysconnectivity in schizophrenia. Am. J. Psychiatry 169, 1092–1099. (doi:10.1176/appi.ajp.2012.12010056)
40. Anticevic A et al. 2015 Association of thalamic dysconnectivity and conversion to psychosis in youth and young adults at elevated clinical risk. JAMA Psychiatry. 72, 882–891. (doi:10.1001/jamapsychiatry.2015.0566)
41. Parnaudeau S, O’Neill PK, Bolkan SS, Ward RD, Abbas AI, Roth BL, Balsam PD, Gordon JA, Kellendonk C. 2013 Inhibition of mediodorsal thalamus disrupts thalamofrontal connectivity and cognition. Neuron 77, 1151–1162. (doi:10.1016/j. neuron.2013.01.038)
42. Bolkan SS, Stujenske JM, Parnaudeau S, Spellman TJ, Rauffenbart C, Abbas AI, Harris AZ, Gordon JA, Kellendonk C. 2017 Thalamic projections sustain prefrontal activity during working memory maintenance. Nat. Neurosci. 20, 987–996. (doi:10. 1038/nn.4568)
43. Spellman T, Rigotti M, Ahmari SE, Fusi S, Gogos JA, Gordon JA. 2015 Hippocampal-prefrontal input supports spatial encoding in working memory. Nature 522, 309–314. (doi:10.1038/nature14445)
44. Schmitt LI, Wimmer RD, Nakajima M, Happ M, Mofakham S, Halassa MM. 2017 Thalamic amplification of cortical connectivity sustains attentional control. Nature 545, 219–223. (doi:10. 1038/nature22073)
45. Guo ZV, Inagaki HK, Daie K, Druckmann S, Gerfen CR, Svoboda K. 2017 Maintenance of persistent activity in a frontal thalamocortical loop. Nature 545, 181–186. (doi:10.1038/nature22324)
46. Baumeister AA, Francis JL. 2002 Historical development of the dopamine hypothesis of schizophrenia. J. Hist. Neurosci. 11, 265–277.
47. Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S. 2012 The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies. Arch. Gen. Psychiatry 66, 13–20. (doi:10. 1001/archgenpsychiatry.2012.169)
48. Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A. 2017 Pathway-specific dopamine abnormalities in schizophrenia. Biol. Psychiatry 81, 31–42. (doi:10.1016/j.biopsych.2016. 03.2104)
49. Demjaha A et al. 2017 Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors. Psychol. Med. 47, 1981–1989. (doi:10.1017/S0033291717000435)
50. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER. 2006 Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49, 603–615.
51. Simpson EH, Kellendonk C. 2017 Insights about striatal circuit function and schizophrenia from a mouse model of dopamine D2 receptor upregulation. Biol. Psychiatry 81, 21–30. (doi:10. 1016/j.biopsych.2016.07.004)
52. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. 2004 Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology 174, 3–16. (doi:10.1007/s00213-004-1793-y)
53. Slifstein M et al. 2015 Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry. 72, 316–324. (doi:10.1001/jamapsychiatry.2014.2414)
54. Gold JM, Waltz JA, Frank MJ. 2015 Effort cost computation in schizophrenia: a commentary on the recent literature. Biol. Psychiatry. 78, 747–753. (doi:10.1016/j.biopsych.2015.05.005)
55. Cazorla M, de Carvalho FD, Chohan MO, Shegda M, Chuhma N, Rayport S, Ahmari SE, Moore H, Kellendonk C. 2014 Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron 81, 153–164. (doi:10. 1016/j.neuron.2013.10.041)
56. Grossman N et al. 2017 Noninvasive deep brain stimulation via temporally interfering electric fields. Cell 169, 1029–1041. (doi:10.1016/j.cell. 2017.05.024)
57. Downs ME, Buch A, Sierra C, Karakatsani ME, Teichert T, Chen S, Konofagou EE, Ferrera VP. 2015 Long-term safety of repeated blood-brain barrier opening via focused ultrasound with microbubbles in non-human primates performing a cognitive task. PLoS ONE 10, e0125911. (doi:10.1371/journal.pone. 0125911)
58. Giovanoli S et al. 2013 Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339, 1095–1099. (doi:10.1126/science.1228261)s